Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00983606 · ClinicalTrials.gov registry record

An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants

A clinical trial of Healthy, sponsored by MedImmune.

Completed
Registry status
3,000
Enrollment target
20
Study locations

NCT00983606: Completed study of Healthy, sponsored by MedImmune.

NCT00983606 is a study of Healthy that has completed, run by MedImmune. The registered enrollment target is 3,000 participants, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (365% higher). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00983606, a study of Healthy, has completed, sponsored by MedImmune.

COMPLETED
Registry status
3,000 participants
Enrollment target
20
Study locations

Study Summary

The primary objective is to assess the burden of respiratory disease in outpatient settings among 32 to 35 weeks' gestational age (wGA) infants in the USA who did not receive RSV prophylaxis during the infants' first RSV season.

Conditions Studied

Study Locations (20)

Alabama

  • Research Site - Birmingham
  • Research Site - Birmingham
  • Research Site - Dothan
  • Research Site - Greenville
  • Research Site - Mobile
  • Research Site - Prattville
  • Research Site - Scottsboro
  • Research Site - Selma
  • Research Site - Sylacauga
  • Research Site - Tuscaloosa

Arizona

  • Research Site - Chandler
  • Research Site - Mesa
  • Research Site - Phoenix
  • Research Site - Prescott
  • Research Site - Scottsdale

Arkansas

  • Research Site - Benton
  • Research Site - Bentonville
  • Research Site - Fort Smith
  • Research Site - Jonesboro
  • Research Site - Little Rock

Trial Details

FieldValue
Enrollment Target 3,000 participants
Start Date 2009-09
Est. Completion 2011-07
MedImmune

210 total trials

What the finished NCT00983606 record still lists

NCT00983606 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 645-participant average among 1,090 other Healthy trials with a reported enrollment target (365% higher).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00983606 names 20 study sites across 3 states, led by Alabama, Arizona, Arkansas.

Frequently Asked Questions

What is clinical trial NCT00983606 about?

NCT00983606 is a clinical study titled "An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants". The primary objective is to assess the burden of respiratory disease in outpatient settings among 32 to 35 weeks' gestational age (wGA) infants in the USA who did not receive RSV prophylaxis during the infants' first RSV season.

What is the current status of trial NCT00983606?

This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2009-09. Estimated completion is 2011-07.

What conditions does trial NCT00983606 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT00983606?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00983606 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00983606's enrollment target sits among peer trials

3,000 17th of 1090 higher than 1,074 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004847 · 3,000 participants · Phase 1

    Diagnosis of Pheochromocytoma

  • NCT00478712 · 3,000 participants

    Hirschsprung Disease Genetic Study

  • NCT00579566 · 3,000 participants

    Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • NCT00816114 · 3,000 participants

    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00983606, the US trial registry maintained by the National Library of Medicine. NCT00983606 (large enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.